• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents.

作者信息

Serruys Patrick W, Daemen Joost

机构信息

Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.

出版信息

Circulation. 2007 Mar 20;115(11):1433-9; discussion 1439. doi: 10.1161/CIRCULATIONAHA.106.666826. Epub 2007 Mar 7.

DOI:10.1161/CIRCULATIONAHA.106.666826
PMID:17344323
Abstract
摘要

相似文献

1
Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents.药物洗脱支架与晚期血栓形成率高于裸金属支架有关吗？晚期支架血栓形成：裸金属支架和药物洗脱支架中都存在的一个麻烦问题。
Circulation. 2007 Mar 20;115(11):1433-9; discussion 1439. doi: 10.1161/CIRCULATIONAHA.106.666826. Epub 2007 Mar 7.
2
Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.第一代药物洗脱支架植入术后晚期支架内血栓形成：一个值得关注的问题。
Circulation. 2007 Mar 20;115(11):1440-55; discussion 1455. doi: 10.1161/CIRCULATIONAHA.106.666800. Epub 2007 Mar 7.
3
[Late stent thrombosis with drug eluting stents: disturbing signals on the radar].[药物洗脱支架的晚期支架内血栓形成：雷达上令人不安的信号]
Ugeskr Laeger. 2007 Apr 23;169(17):1561-3.
4
The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.药物洗脱支架植入术后晚期及极晚期支架内血栓形成的难题。
Curr Opin Cardiol. 2007 Nov;22(6):565-71. doi: 10.1097/HCO.0b013e3282f02100.
5
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.西罗莫司洗脱支架植入术后5年临床结局：来自4项比较西罗莫司洗脱支架与裸金属支架的随机试验患者水平汇总分析的见解
J Am Coll Cardiol. 2009 Sep 1;54(10):894-902. doi: 10.1016/j.jacc.2009.04.077.
6
The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents versus bare-metal stents during percutaneous coronary intervention.在经皮冠状动脉介入治疗期间，与裸金属支架相比，药物洗脱支架患者的平均支架长度更长，平均支架直径更短。
Am J Ther. 2007 May-Jun;14(3):277-9. doi: 10.1097/MJT.0b013e3180653377.
7
Drug-eluting stents: towards new endpoints.药物洗脱支架：迈向新的终点。
Minerva Cardioangiol. 2006 Oct;54(5):521-37.
8
Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.药物洗脱支架与裸金属支架在非开口处近端左前降支冠状动脉中的疗效比较。
Am J Cardiol. 2009 Feb 15;103(4):496-500. doi: 10.1016/j.amjcard.2008.10.028.
9
Drug-eluting coronary stents: many meta-analyses, little benefit.药物洗脱冠状动脉支架：众多荟萃分析，获益寥寥。
Prescrire Int. 2009 Apr;18(100):70-4.
10
Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.可降解药物洗脱支架：冠心病治疗的新前沿。
Expert Rev Med Devices. 2005 Nov;2(6):667-71. doi: 10.1586/17434440.2.6.667.

引用本文的文献

1
Comparison of long-term clinical outcomes of bioabsorbable polymer versus durable polymer drug-eluting stents: a systematic review and meta-analysis.生物可吸收聚合物与耐用聚合物药物洗脱支架的长期临床结果比较：一项系统评价和荟萃分析。
Egypt Heart J. 2024 Jul 10;76(1):91. doi: 10.1186/s43044-024-00522-1.
2
A more-Comers populAtion trEated with an ultrathin struts polimer-free Sirolimus stent: an Italian post-maRketing study (the CAESAR registry).一项关于使用超薄支架无聚合物西罗莫司洗脱支架治疗更多患者人群的研究：一项意大利上市后研究（凯撒注册研究）
Front Cardiovasc Med. 2024 Jan 8;10:1326091. doi: 10.3389/fcvm.2023.1326091. eCollection 2023.
3
Safety and Clinical Performance of Biodegradable Polymer-Coated Ultra-Thin Everolimus-Eluting Stents in "Real-World" Patients: A Multicenter Registry (PERFORM-EVER).
生物可降解聚合物涂层超薄依维莫司洗脱支架在“真实世界”患者中的安全性和临床性能：多中心注册研究（PERFORM-EVER）。
Anatol J Cardiol. 2022 Aug;26(8):619-628. doi: 10.5152/AnatolJCardiol.2022.844.
4
Prevalence of coronary calcification on preoperative computed tomography and its management in thoracic surgery.术前计算机断层扫描冠状动脉钙化的发生率及其在胸外科的处理。
Surg Today. 2023 Jan;53(1):62-72. doi: 10.1007/s00595-022-02532-5. Epub 2022 Jun 13.
5
Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials.普拉格雷与替格瑞洛用于接受经皮冠状动脉介入治疗的急性冠脉综合征患者：对随机对照试验的批判性评价
Ann Med Surg (Lond). 2022 Feb 7;74:103330. doi: 10.1016/j.amsu.2022.103330. eCollection 2022 Feb.
6
The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective.2010年代临床药物洗脱支架和生物可吸收支架研究：荷兰视角
Neth Heart J. 2020 Aug;28(Suppl 1):78-87. doi: 10.1007/s12471-020-01442-w.
7
and evaluation of a dextran-graft-polybutylmethacrylate copolymer coated on CoCr metallic stent.以及对涂覆在钴铬金属支架上的葡聚糖接枝聚甲基丙烯酸丁酯共聚物的评估。
Bioimpacts. 2019;9(1):25-36. doi: 10.15171/bi.2019.04. Epub 2018 Oct 2.
8
Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction.急性心肌梗死患者中可生物降解聚合物涂层薄支架西罗莫司洗脱支架与耐用聚合物涂层依维莫司洗脱支架的安全性和有效性比较
Postepy Kardiol Interwencyjnej. 2018;14(4):347-355. doi: 10.5114/aic.2018.79194. Epub 2018 Nov 9.
9
Pathogenesis of late in-stent thrombosis after treatment with drug-eluting stents.药物洗脱支架治疗后晚期支架内血栓形成的发病机制。
J Cardiol Cases. 2012 Sep 18;6(5):e158-e160. doi: 10.1016/j.jccase.2012.08.005. eCollection 2012 Nov.
10
Clinical performance of a novel ultrathin strut, low-dose, sirolimus-eluting stent with abluminal-only biodegradable polymeric coating for patients undergoing percutaneous coronary intervention in the daily practice.一种新型超薄支架梁、低剂量、仅在管腔外有可生物降解聚合物涂层的西罗莫司洗脱支架在日常经皮冠状动脉介入治疗患者中的临床性能。
Cardiovasc Diagn Ther. 2015 Dec;5(6):414-9. doi: 10.3978/j.issn.2223-3652.2015.07.07.